Poll finds a quarter of people with Parkinson’s are wrongly diagnosed
In our survey of more than 2,000 people, more than a quarter (26%) reported they were misdiagnosed with a different condition before receiving the correct Parkinson’s diagnosis.
Scottish Government's £4.5m plan for neurological care and support
Scottish Government announces long-awaited neurlogical plan
Parkinson’s and the Queen’s Speech
Here's what the Queen's Speech means for people with Parkinson's, their carers and families.
Congratulations to our volunteer award winners
we announce the winners of our first volunteer awards
Full results of repurposed cancer drug trial highlight potential benefits
Previous top line results indicated that, while safe, Nilotinib failed to show benefit. The full results now show that there may be some potential benefits.
8 remarkable things we achieved together in 2019, and recent years
2019 was another exciting year of progress. Here are 8 of the highlights, and 8 ways you can still get involved.
New international initiative to investigate the genetics of Parkinson’s
As part of the Aligning Science Across Parkinson’s (ASAP) initiative, an ambitious global five-year programme was announced today to understand the genetic root of Parkinson’s.
Results of phase 2 nilotinib study show no benefit
Results have been shared from the US-based phase 2 clinical trial of nilotinib in people with moderate to advanced Parkinson's.
While safe and tolerable, the repurposed drug did not appear to have beneficial effects.
The Parkinson’s Choir Christmas single
The Horsham and District local group is attempting to achieve big things with their 2019 single, ‘This Christmas Time’.
Progress in gene therapy treatment for Parkinson's
Researchers, funded by Parkinson's UK, have produced positive results in mice for a gene therapy treatment that directly targets the production of the alpha-synuclein protein.